Nanospectra Biosciences Announces Enrollment Completion of Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue

by NASDAQ Market News November 2, 2021

NASDAQ Market News
Click here to email author

U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

iOnctura to Share Preclinical Data on IOA-289 at SITC in November

Ads